iSpecimen (ISPC)
NASDAQ:ISPC
Total Valuation
iSpecimen has a market cap or net worth of $3.44M. The enterprise value is -$6.01M.
Market Cap$3.44M
Enterprise Value-$6.01M
Share Statistics
iSpecimen has 29,662,250 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding29,662,250
Owned by Insiders―
Owned by Institutions<0.01%
Financial Efficiency
iSpecimen’s return on equity (ROE) is -3.40 and return on invested capital (ROIC) is -267.44%.
Return on Equity (ROE)-3.40
Return on Assets (ROA)-1.10
Return on Invested Capital (ROIC)-267.44%
Return on Capital Employed (ROCE)-2.72
Revenue Per Employee80.37K
Profits Per Employee-436.98K
Employee Count24
Asset Turnover0.20
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of iSpecimen is ―. iSpecimen’s PEG ratio is 0.00131.
PE Ratio―
PS Ratio0.62
PB Ratio0.39
Price to Fair Value0.39
Price to FCF-0.28
Price to Operating Cash Flow-0.12
PEG Ratio0.00131
Income Statement
In the last 12 months, iSpecimen had revenue of 1.93M and earned -10.49M in profits. Earnings per share was -2.28.
Revenue1.93M
Gross Profit24.11K
Operating Income-8.98M
Pretax Income-10.49M
Net Income-10.49M
EBITDA-8.75M
Earnings Per Share (EPS)-2.28
Cash Flow
In the last 12 months, operating cash flow was -4.24M and capital expenditures -451.00, giving a free cash flow of -4.24M billion.
Operating Cash Flow-4.24M
Free Cash Flow-4.24M
Free Cash Flow per Share-0.14
Dividends & Yields
iSpecimen pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.04
52-Week Price Change-91.07%
50-Day Moving Average0.23
200-Day Moving Average0.68
Relative Strength Index (RSI)30.55
Average Volume (3m)8.88M
Important Dates
iSpecimen upcoming earnings date is Oct 30, 2025, Before Open (Confirmed).
Last Earnings DateAug 12, 2025
Next Earnings DateOct 30, 2025
Ex-Dividend Date―
Financial Position
iSpecimen as a current ratio of 1.12, with Debt / Equity ratio of 8.70%
Current Ratio1.12
Quick Ratio1.12
Debt to Market Cap0.00
Net Debt to EBITDA0.76
Interest Coverage Ratio-4.61K
Taxes
In the past 12 months, iSpecimen has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
iSpecimen EV to EBITDA ratio is 0.62, with an EV/FCF ratio of 1.28.
EV to Sales-2.81
EV to EBITDA0.62
EV to Free Cash Flow1.28
EV to Operating Cash Flow1.28
Balance Sheet
iSpecimen has $6.88M in cash and marketable securities with $268.80K in debt, giving a net cash position of $6.61M billion.
Cash & Marketable Securities$6.88M
Total Debt$268.80K
Net Cash$6.61M
Net Cash Per Share$0.22
Tangible Book Value Per Share$0.45
Margins
Gross margin is 1.25%, with operating margin of -465.42%, and net profit margin of -543.68%.
Gross Margin1.25%
Operating Margin-465.42%
Pretax Margin-543.68%
Net Profit Margin-543.68%
EBITDA Margin-453.43%
EBIT Margin-543.16%
Analyst Forecast
The average price target for iSpecimen is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-67.73%
EPS Growth Forecast58.35%